Singh Shawn

CIK 00014120712 companiesFRANKLIN, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001412071

Recent Transactions

50 trades

Award
Vistagen Therapeutics, Inc.$VTGN
Common Stock
2025-06-30$1.70/sh+7,541→ 18,028 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2025-06-23+300,000→ 300,000 total
Award
Vistagen Therapeutics, Inc.$VTGN
Common Stock
2024-06-28$2.96/sh+4,854→ 10,487 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2024-06-24+500,000→ 500,000 total
Award
Vistagen Therapeutics, Inc.$VTGN
Common Stock
2023-12-29$1.72/sh+167→ 5,633 total
Award
Vistagen Therapeutics, Inc.$VTGN
Common Stock
2023-06-30$1.59/sh+167→ 5,466 total
Award
Vistagen Therapeutics, Inc.$VTGN
Common Stock
2022-12-30$0.09/sh+5,000→ 158,998 total
Purchase
Vistagen Therapeutics, Inc.$VTGN
Common Stock
2022-08-17$0.17/sh+600,000→ 626,234 total
Award
Vistagen Therapeutics, Inc.$VTGN
Common Stock
2022-06-30$0.75/sh+5,000→ 153,998 total
Exercise/Conversion
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2022-05-12−100,000→ 70,000 total
Exercise/Conversion
Vistagen Therapeutics, Inc.$VTGN
Common Stock
2022-05-12$1.00/sh+100,000→ 148,998 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2022-03-01+300,000→ 300,000 total
Award
Vistagen Therapeutics, Inc.$VTGN
Common Stock
2021-12-31$1.66/sh+3,623→ 48,998 total
Award
Vistagen Therapeutics, Inc.$VTGN
Common Stock
2021-06-30$1.95/sh+5,000→ 45,375 total
Exercise/Conversion
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2021-04-23−5,000→ 0 total
Exercise/Conversion
Vistagen Therapeutics, Inc.$VTGN
Common Stock
2021-04-23$1.50/sh+5,000→ 40,375 total
Award
Vistagen Therapeutics, Inc.$VTGN
Common Stock
2020-12-31$0.45/sh+5,000→ 35,375 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2020-12-30+300,000→ 300,000 total
Award
Vistagen Therapeutics, Inc.$VTGN
Common Stock
2020-06-30$0.45/sh+5,000→ 30,375 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2020-04-23+300,000→ 300,000 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2019-10-21+300,000→ 300,000 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2019-05-28+170,000→ 170,000 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2019-05-23+80,000→ 80,000 total
Exercise/Conversion
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2019-01-14−1,125→ 0 total
Exercise/Conversion
Vistagen Therapeutics, Inc.$VTGN
Common Stock
2019-01-14$1.50/sh+1,125→ 22,375 total
Exercise/Conversion
Vistagen Therapeutics, Inc.$VTGN
Common Stock
2019-01-14$1.50/sh+3,000→ 25,375 total
Exercise/Conversion
Vistagen Therapeutics, Inc.$VTGN
Common Stock
2019-01-14$1.50/sh+21,250→ 21,250 total
Exercise/Conversion
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2019-01-14−3,000→ 0 total
Exercise/Conversion
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2019-01-14−21,250→ 0 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2019-01-14$1.70/sh+220,000→ 220,000 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-29+1,125→ 1,125 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-29+5,000→ 5,000 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-29+175,000→ 175,000 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-29+3,000→ 3,000 total
Disposition to Issuer
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-29−50,000→ 0 total
Disposition to Issuer
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-29−1,125→ 0 total
Disposition to Issuer
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-29−175,000→ 0 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-29+50,000→ 50,000 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-29+21,250→ 21,250 total
Disposition to Issuer
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-29−100,000→ 0 total
Disposition to Issuer
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-29−21,250→ 0 total
Disposition to Issuer
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-29−5,000→ 0 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-29+200,000→ 200,000 total
Disposition to Issuer
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-29−3,000→ 0 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-29+100,000→ 100,000 total
Disposition to Issuer
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-29−200,000→ 0 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-02-02+300,000→ 300,000 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2017-09-19+125,000→ 125,000 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2017-04-26+175,000→ 175,000 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2016-11-09+100,000→ 100,000 total

Singh Shawn

Recent Transactions

Companies

Recent Filings

Address